40
Renovare Therapeutics raises $1M in first offering under Reg D 506(b)
Company raise · Raising · BOULDER, CO · Form D filed 2026-10-02
Renovare Therapeutics, a Delaware biotech corporation incorporated in 2026, is raising up to $1M under Regulation D 506(b) exemption. The company has sold $100K to one investor as of September 14, 2026, and seeks $900K more.
Note: Company incorporated in 2026 and filed Form D in October 2026; first raise on EDGAR; no placement agent listed.
First raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Elizabeth A Scott | Executive Officer, Director |
| Stephanie Bryant | Director |
| Karin Payne | Executive Officer |
Signed by Elizabeth A. Scott, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.